
Dr. Doruk Erkan is an Associate Physician-Scientist at the Barbara Volcker Center for Women and Rheumatic Diseases, Associate Attending Rheumatologist and Clinical Researcher at Hospital for Special Surgery, and Associate Professor of Medicine at Weill Cornell Medical College.
In addition to his rheumatology practice, Dr. Erkan has a long-standing research interest in Antiphospholipid Syndrome (an autoimmune clotting disorder) and Systemic Lupus Erythematosus (SLE or “lupus”). After his Internal Medicine residency at Beth Israel Medical Center in New York, he completed his Rheumatology fellowship at Hospital for Special Surgery in New York. Dr. Erkan has a medical doctor (MD) degr...
Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry").
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with aPLs: an APS ACTION Registry study.
Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.